AAQ1 — aap Implantate AG Share News
0.000.00%
Last trade - 00:00- €24.72m
- €23.67m
- €12.49m
Brief: Aap Receives Funding For Its Innovative Antibacterial Silver Coating Technology
Brief: Aap Implantate Q2 EBITDA Improved To EUR -1.5 Mln
Brief: Aap Implantate Q1 EBITDA Loss Narrows To EUR 1.6 Million
Brief: Aap Implantate Sees 2018 EBITDA Of EUR -5.0 Million To EUR -3.4 Million
Brief: Aap Implantate: Progress Regarding Preparations For Human Clinical Study in Antibacterial Silver Coating Technology
Brief: Aap Implantate FY Sales Up At EUR 11 Mln
Brief: aap Implantate sees FY sales and EBITDA at lower end of guidance
Brief: aap Implantate Q2 EBITDA loss widens to 1.6 million euros
Brief: Aap Implantate: resolution on capital reduction
Brief: Aap Implantate announces public share buyback offer
Brief: aap Implantate Q1 sales up 23 pct at 3.1 million euros
Brief: aap Implantate concludes distribution agreement for LOQTEQ radius system
Brief: aap Implantate 2016 sales and EBITDA below guidance
Brief: aap Implantate Q4 sales stable at 2.4 million euros
Brief: Aap Implantate completes sale of remaining stake in aap Joints GmbH
Brief: Aap concludes distribution contract with U.S. healthcare service provider
Brief: Aap Implantate will not achieve previous FY 2016 sales and EBITDA forecast for continued operation
Brief: aap Implantate Q3 EBITDA loss widens to 1.8 mln euros in continued operation
Brief: Aap Implantate post Q2 EBITDA loss from continued oprations of 1.4 mln euros